Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.
about
Big Data Analytics for Prostate RadiotherapyLate rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelTransitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysisPrediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.Radiation dose-volume effects in radiation-induced rectal injury.On voxel-by-voxel accumulated dose for prostate radiation therapy using deformable image registration.Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.Analysis of radiation pneumonitis risk using a generalized Lyman model.Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancerPersonalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancerClinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters.A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model.Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlasPredictors of high-grade esophagitis after definitive three-dimensional conformal therapy, intensity-modulated radiation therapy, or proton beam therapy for non-small cell lung cancer.Gastrointestinal toxicity associated to radiation therapy.Emerging technologies in prostate cancer radiation therapy: improving the therapeutic window.Reducing rectal injury during external beam radiotherapy for prostate cancer.The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques.Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy.Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancerDose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy.Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.Clinical and dosimetric predictors of late rectal bleeding of prostate cancer after TomoTherapy intensity modulated radiation therapy.Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.The future of predictive models in radiation oncology: from extensive data mining to reliable modeling of the results.A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.Feasibility of safe ultra-high (EQD(2)>100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by Helical Tomotheraphy.An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer.Efficacy of a rectal spacer with prostate SABR - first UK experience.Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.Interindividual registration and dose mapping for voxelwise population analysis of rectal toxicity in prostate cancer radiotherapy.Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning.Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer: a comparison between dose-volume constraints and NTCP use.The contribution of the cone beam Kv CT (CBKvCT) to the reduction in toxicity of prostate cancer treatment with external 3D radiotherapy
P2860
Q26744485-CE284A49-B687-479E-9FF6-DE6A50033CC9Q34238364-29A39143-6EAA-44F2-9932-A0B6B18DD0F9Q34500966-AC153457-B120-4423-83CD-B1FFB09282B5Q35500065-FC0D762D-9029-4B00-9AC7-D93FBC1BBBCAQ35870610-FD9970CC-33E5-40A3-BFFD-3772C8B10C06Q36011188-68D8B478-4688-4387-81AE-704CBB9BDF0DQ36145910-5CBB1AC2-5987-4235-B820-851ADA039562Q36202855-7C9D356B-4EC2-42A2-BB4A-582A84E8C60EQ36235629-C23417F8-ED44-46F7-B1F5-55BD9910730EQ36672732-76967C0B-C675-4CE3-884F-24E89E807042Q36679026-B0F6EE93-2D82-4D02-9D62-237FF5FC47A6Q37113684-4EAEB9D2-5D7E-40B9-BD33-FF794864E61BQ37198226-707E5DF2-9630-4EC4-9456-D1C5080AC204Q37523270-02DF210F-974B-4559-ADBC-C4AE64332064Q37633737-A833D47B-A6CA-43AA-8748-A3E457765123Q37780019-4C937EDA-66B7-4885-A62D-5F3ABEC72481Q37791392-C98E8D30-0930-4DCE-B029-FFA84A442D37Q38106626-FB2FF0AF-D4DE-4ECE-A147-66759B5A6C50Q38266168-DF289E1A-BC7B-4272-AFF6-430A32BFD79AQ38721165-B9D928AF-9F8D-4B8D-B8E8-4BEC10EBDD3AQ38981805-44780F15-9D7C-4581-A346-2CE72F4A0CB9Q39527795-FFD6E6C2-54A6-499C-8F7A-4E795CF11809Q39532552-ABF9A9AE-8015-4767-87EE-F891B718E95FQ41276603-6DCCD5A8-1D21-4E8E-A7E9-7B5A1E32B4B7Q41541961-ED0F5FFF-7FF4-4C35-A720-8D6D265BA4B7Q41633588-A655A9F6-78D3-474F-A799-01F46594ECECQ42537131-2012EA21-88EB-42DA-BF28-75A5CE5A2038Q44073308-FF9F6078-DA4C-4432-A5D3-8A8675E182A7Q45038563-FC550B64-1B74-4003-B41B-958530BD0DEFQ45070750-E01C7247-D7E2-40FC-927D-0C317A254C67Q45253735-B4066368-9097-4BEA-9DD2-0C6EDA88AB58Q46838608-236FD01D-2E48-4C0A-BDFC-B40BA0E4C486Q47226698-B600A5D0-794C-47BC-967B-AF3A95F4B8D9Q48004310-50447F51-65DB-41CD-A8B8-DDCD91AECCC5Q51571128-2FA6C75C-9290-4E98-A7F2-D93524A5BCECQ51699959-D873E202-4E63-44E8-84EF-4D5A2285D9C3Q51826236-F8AD3F66-7BFF-4A1E-BD5B-20587D5EBCA3Q58656934-09463A18-C3F1-47CB-A2C1-6B86C4D8DEB0
P2860
Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Rectal bleeding, fecal inconti ...... lication probability modeling.
@en
Rectal bleeding, fecal inconti ...... lication probability modeling.
@nl
type
label
Rectal bleeding, fecal inconti ...... lication probability modeling.
@en
Rectal bleeding, fecal inconti ...... lication probability modeling.
@nl
prefLabel
Rectal bleeding, fecal inconti ...... lication probability modeling.
@en
Rectal bleeding, fecal inconti ...... lication probability modeling.
@nl
P2093
P1476
Rectal bleeding, fecal inconti ...... lication probability modeling.
@en
P2093
Augustinus A M Hart
Joos V Lebesque
Mischa S Hoogeman
Peter C M Koper
Stephanie T H Peeters
Wilma D Heemsbergen
P356
10.1016/J.IJROBP.2006.03.034
P407
P577
2006-06-06T00:00:00Z